Literature DB >> 33634040

Oral rehydration salts therapy use among children under five years of age with diarrhea in Ethiopia.

Nasser B Ebrahim1, Madhu S Atteraya2.   

Abstract

Background: Oral rehydration salts (ORS) therapy for diarrheal diseases is considered an effective therapy that can be applied in many resource-poor settings. Nevertheless, it has been consistently underutilized, and as a result, its potential to reduce child mortality has not been fully exploited. In Ethiopia, the use of ORS therapy for children under five has been inadequate. Like any other health behavior, the provision of ORS therapy to children during diarrheal episodes by caregivers is complex and context dependent. Identifying the factors may help promote wider application. Design and methods: We used data from the 2016 Ethiopia Demographic and Health Survey (EDHS-2016). Samples were selected by a two-stage stratified cluster sampling method. We used data on children under five years of age whose mothers (aged 15-49 years) reported that the child had had diarrhea within two weeks before the survey was conducted (n=1221). The dependent variable was whether these children received ORS therapy. The contextual independent factors were socio-demographic variables (mothers' age, child's age, child's sex, child's place of residence, household wealth, and mother/ husband/partner's education levels and work status), as well as media exposure and healthcare utilization.
Results: The prevalence of ORS therapy use among the children was 30%. Mothers who had made at least four prenatal visits during their last pregnancy were 87% more likely to use ORS therapy for their children than those who had fewer prenatal visits (OR=1.874; CI: 1.140-3.082; p=0.013). Conclusions: Integrating efforts for scaling-up ORS use with prenatal health care services may have an extra benefit of promoting children's wellbeing and survival. ©Copyright: the Author(s).

Entities:  

Keywords:  Africa; Ethiopia; ORS; children; contextual factors

Year:  2021        PMID: 33634040      PMCID: PMC7883012          DOI: 10.4081/jphr.2021.1732

Source DB:  PubMed          Journal:  J Public Health Res        ISSN: 2279-9028


Introduction

Worldwide, diarrhea is the second leading cause of mortality among children under five years of age and claims the lives of 525,000 children annually.[1,2] The overwhelming majority (90%) of deaths from diarrhea in 2016 occurred in Sub-Saharan Africa and South Asia,[3] disproportionately affecting children living in areas with poor sanitation, unsafe water, and inadequate access to health services.[4] As well, in Ethiopia, diarrheal diseases are the second leading cause of under-five mortality.[4] Most of these deaths can be prevented through cost-effective interventions that can easily be applied in resource-poor settings.[1,5,6] Diarrheal diseases cause death by severe dehydration and fluid loss, as well as through the systemic blood infections sometimes associated with them.[2] Beyond causing significant mortality and morbidity, diarrheal diseases can negatively impact children’s early growth, perhaps by interfering with nutrient absorption.[7] The World Health Organization’s Integrated Management of Childhood Illness (IMCI) guidelines recommend that diarrhea case management include oral rehydration therapy (ORT) in conjunction with continuous breast feeding and zinc supplementation to prevent lethal outcomes of diarrheal episodes among children.[8] ORT entails the use of oral rehydration salts (ORS) and recommended home fluids.[9] ORS is considered a lynchpin of ORT and has been reported to prevent 93% of mortalities from diarrhea,[9] which has significantly contributed to the decline in mortality from diarrheal diseases among children.[6] ORS were discovered half a century ago and have been widely available for decades. Nevertheless, despite the therapy’s remarkable health outcomes, it is consistently underutilized,[10] with 62% of children in low and middle-income countries still not receiving ORS treatment for diarrheal diseases.[1] Similarly, results from the 2016 Ethiopia Demographic and Health Survey (EDHS-2016) showed that among children under five with diarrhea, only 30% received ORS therapy.[11] Like any other health behavior, the provision of ORS therapy to children during diarrheal episodes by caregivers is complex and context dependent. Contextual factors could have the potential to influence the manifestation of this behavior. Hence, we aimed to assess the association between contextual factors of caregivers (socio-demographic factors, media exposure, and health care utilization) and their use of ORS therapy for children under five with diarrhea from a nationally representative sample in Ethiopia. Our study may have the potential to contribute to expanding the use of ORS therapy in children suffering from diarrheal diseases and improving their survival.

Methods

Sample design

We used data from EDHS-2016, which is typically conducted every five years, provides key demographic and health indicators at the national level. Samples were selected by a two-stage stratified cluster sampling method. In the first stage, 645 sampling units also called enumeration areas (EAs) which included 202 and 443 urban and rural sites, respectively, were selected through probability sampling method. In the second stage, equal probability systematic sampling was used to select 28 households per cluster.[12] The sampling method and ethical considerations in conducting the survey have been detailed in a report by the Central Statistical Agency of Ethiopia.[11]We used data from children under five years of age whose mothers (aged 15-49 years) reported that their children had diarrhea within two weeks before the survey was conducted (n=1221). However, mothers were not asked the number of bowel movements or the extent of decrease in stool consistencies. [11] The response rate for the face-to face EDHS-2016 was 98% and data on non-respondents were not available.[11] Using G*Power software, we ran post hoc power analysis. Assuming small effect size (OR=1.68) and 30% proportion of cases (ORS prevalence) and an alpha level of 0.05, a sample size of 1221 had enough statistical power, i.e. 93% probability of detecting significant differences between variables.

Measurements

The dependent variable was whether the children received (ORS) therapy. The contextual independent factors were sociodemographic variables (mothers’ age, child’s age, child’s sex, child’s place of residence, household wealth, and mother/ husband/ partner’s education levels and work status), as well as media exposure and healthcare utilization. Descriptions of variables and categories are presented in Table 1.
Table 1.

Variable description and categorization

VariableDescriptionsCategories
Dependent variable
    Received oral rehydration salts (ORS) therapyChildren under-five who whose mothers reported to have diarrhea 2-weeks before surveyReceived no ORS therapy=0; Received ORS therapy=1
Independent variables
    Mother’s ageMother age in years15-24=0; 25-34=1, 35-49=2
    Child age under 5Child age in months0-11=0; 12-35=1; 36-59=2
    Child sexMale/ femaleMale=1; female =0
    ResidenceRural/urbanRural=0; urban=1
    Household wealthWealth index (generated from household income, consumption, and expenditures)Poor=0; middle=1; rich=2
Educational levelMother/husband/partner’s educationNo education=0; primary=1; secondary and higher=2
Employment statusMother/husband/partner’s employment statusUnemployed=0; employed=1
Media exposureFrequency of reading newspaper or magazineNo exposure=0;
Frequency of listening to radioany exposure=1
Frequency of watching television
Health care utilization
    Prenatal care visit*Number of antenatal visits in the last pregnancy0-3 visits during pregnancy=0; ≥ 4 visits during pregnancy=1
Health care visit for any serviceVisited health facility in the last 12 monthsNo=0; Yes=1

The new WHO guidelines increased contacts between pregnant women and provider from four to eight;[13] however, we used the previous guidelines of at least four visits of antenatal care during pregnancy because of the limited number of women who at least had eight contacts and used ORS therapy for children.

Data analysis

For the data analysis, we used a module for complex data analysis in SPSS v. 25.0. Sampling weights were applied, and effects associated with the complex survey design were accounted for. Descriptive statistical analyses were run, and bivariate associations were tested by the chi-square statistic for variables in the study (socio-demographic variables, media exposure and heath care utilization). In the multivariate analysis, independent variables that showed bivariate associations with the dependent variable with p<0.3 were chosen for further analysis and examined by a multivariate logistic regression model. A p-value of less than 0.05 was used to determine statistical significance.

Results

The prevalence of ORS therapy use among children under five years of age who had diarrhea within two weeks before the survey was 30% (Table 2). At the bivariate level, the mother’s age, place of residence, and number of prenatal visits were significantly associated with ORS therapy. The rest of the variables showed no significant associations with ORS therapy use (Table 2). At the multivariate level, the only variable that showed a significant association (OR=1.874; CI: 1.140-3.082; p=0.013) with ORS therapy for children was prenatal health care utilization by the mothers in their last pregnancies. Mothers who had made at least four prenatal visits during their last pregnancy were 87% more likely to use ORS therapy for their children with diarrhea than mothers who had fewer prenatal visits. However, mothers visiting a health care facility for general health purposes was not associated with ORS use for their children with diarrhea (Table 3).
Table 2.

Contextual factors related to ORS therapy use in children under 5 who had diarrhea in the 2-weeks before the survey.

ORS therapy use for children under 5 who had diarrhea in the 2-weeks before the survey
VariablesSubtotalNo n (%)Yes n (%)Χ2/p
Mother’s age in years
    15-24303220 (72.8)83 (27.2) 
    25-34669489 (73.1)180 (26.9)14.80/0.034
    35-49249149 (59.8)100 (40.2)
Child age in months
    0-11329247 (75.2)82 (24.8)5.28/0.272
    12-35604408 (67.6)196 (32.4)
    36-59288203 (70.5)85 (29.5)
Child sex
    Male642446 (69.5)196 (30.5)0.192/0.618
    Female578412 (71.2)166 (28.8)
Residence
    Rural1095783 (71.6)311 (28.4)
    Urban12675 (59.5)51 (40.5)7.082/0.038
Household wealth
    Poor534388 (72.6)147 (27.4)2.389/0.585
    Middle265178 (67.2)87 (32.8)
    Rich422293 (69.4)129 (30.6)
Mother’s education
    No education763549 (72.0)214 (28.0)
    Primary367250 (68.2)117 (31.8)2.769/0.477
    Secondary and higher9159 (64.9)32 (35.1)
Husband/partner education
    No education489352 (72.1)137 (27.9)
    Primary514373 (72.7)140 (27.3)10.369/0.076
    Secondary and higher14283 (58.4)59 (41.6)
Mother’s employment status
    Unemployed848608 (71.7)240 (28.3) 
    Employed373251 (67.1)123 (32.9)2.321/0.265
Husband/partner employment status
    Unemployed8961 (68.8)28 (31.2)0.610/0.786
    Employed1060752 (71.0)308(29)
Media exposure
    No797573 (71.8)225 (28.2)2.262/0.282
    Yes423286 (67.5)138 (32.5)
Number of prenatal visit (last pregnancy)
    0-3683510 (74.7)173 (25.3)20.238/0.001
    4+355214 (60.3)141 (39.7)
Visited health facility in the last 12 months
    No490360 (73.4)130 (26.6)3.21/0.214
    Yes731499 (68.2)232 (31.8)
Total n (%)1221858 (70.3)362 (29.7)

p Probability of significant associations (Pearson’s Chi-square); some subtotals are different from the total count in cross-tabulation because of missing data and/or cell count rounding. All numbers are weighted.

Table 3.

Adjusted odd-ratios (OR) and 95% confidence (95%CI): ORS therapy use for children under 5 who had diarrhea in the 2- weeks before the survey

VariablesOR95% CIp
Mother’s age in years
    15-241
    25-340.8500.483-1.4950.093
    35-491.4900.773-2.874 
Child age in months
    0-111
    12-351.4430.900-2.3150.288
    36-591.5270.759-3.073
Residence
    Rural1
    Urban1.1160.573-2.170.747
Husband/partner education
    No education1
    Primary0.8740.531-1.4360.396
    Secondary and higher1.3360.698-2.557
Mother’s employment status
    Unemployed1
    Employed1.0270.653-1.6130.909
Media exposure
    Yes10.718-1.9060.528
    No1.170
Number of antenatal visits (last pregnancy)
    0-310.013
    4+1.8741.140-3.082
Visited health facility in the last 12 months
    No10.376
    Yes1.2420.768-2.007
Variable description and categorization The new WHO guidelines increased contacts between pregnant women and provider from four to eight;[13] however, we used the previous guidelines of at least four visits of antenatal care during pregnancy because of the limited number of women who at least had eight contacts and used ORS therapy for children.

Discussion

The prevalence of ORS therapy among children under five with diarrhea was 30%, meaning only one in three children under five with diarrhea receive ORS therapy in Ethiopia. Nonetheless, the lower use in Ethiopia is on par with the global and African averages,[6] which is revelatory of the underutilization of this costeffective treatment throughout the world.[12] Barriers cited for expanding the use of ORS therapy include cost, lack of awareness, and availability.[13-16] The United Nation’s Sustainable Development Goals (SDGs) target the end of preventable mortality for neonates and children under five by 2030.[17] For example, in India, public and private sectors were involved in targeting demand and supply barriers for ORS therapy - a strategy that boosted ORS therapy coverage,[6] could as well help Ethiopia achieve child survival SDGs. The lack of significant associations between the use of ORS therapy and all the variables in the study except the mothers’ use of prenatal health services indicate the universality of ORS underutilization by different segments of the study population. Also, our preliminary analysis showed no significant difference between breastfeeding and non-breastfeeding mothers’ in the use of ORS for their children. Among interventions to increase ORS therapy coverage, integrating ORS use efforts in the existing health services has been suggested.[18] Among the contextual factors examined in this study, only prenatal health care utilization by mothers was significantly (OR=1.874; CI: 1.140-3.082; p=0.013) associated with ORS use in children. Women who had visited prenatal services four times or more during their last pregnancy were 87% more likely to use ORS therapy for their children with diarrhea. However, visiting health care facility for other purposes was not associated with increased likelihood of using ORS therapy. Hence, integrating ORS scaling-up efforts with expanded prenatal health care services for pregnant women may have extra benefit of promoting children’s wellbeing and survival. The EDHS-2016 results showed that only 32% of the women had visited prenatal care centers at least four times during their last pregnancy.[11] Thus, there is a huge potential for expanding prenatal health services and improving child survival. Main barriers that could constrain prenatal health care utilization in Ethiopia include widespread nonavailability of the services, long distance to health facilities, and lower women’s decision-making autonomy.[19] Addressing these barriers may as well enhance ORS use among children. Ultimately, risk reduction for diarrheal diseases should focus on promoting good sanitation and safe drinking water. Nonetheless, expanded use of ORS therapy coverage is needed to further reduce preventable child mortality in Ethiopia. Contextual factors related to ORS therapy use in children under 5 who had diarrhea in the 2-weeks before the survey. p Probability of significant associations (Pearson’s Chi-square); some subtotals are different from the total count in cross-tabulation because of missing data and/or cell count rounding. All numbers are weighted.

Study strengths and limitations

Unlike previous studies, one of the strengths of this study is that the results can be generalized to the Ethiopian population at large because we used a nationally representative sample with very good data quality control procedures and processes. Moreover, we used data on mothers’ self-reported use of ORS for children with diarrhea just two weeks before the survey was conducted, which substantially reduces the recall bias inherent in surveys when past experiences are probed. However, our study has limitations similar to those of other studies based on cross-sectional data. In addition, mothers were not asked the number of bowel movements or extent of decrease in stool consistencies. As well, mothers’ ORS use knowledge was not assessed.

Conclusions

The 30% prevalence of ORS use among children under five with diarrhea is inadequate. ORS use features cost-effectiveness and potential benefits of averting adverse health outcomes for children with diarrheal episodes. Thus, wider ORS coverage is invaluable. Integrating efforts for scaling-up ORS use with prenatal health care services for pregnant women may also enhance children’s wellbeing and survival. Adjusted odd-ratios (OR) and 95% confidence (95%CI): ORS therapy use for children under 5 who had diarrhea in the 2- weeks before the survey
  12 in total

1.  Health care systems in low- and middle-income countries.

Authors:  Anne Mills
Journal:  N Engl J Med       Date:  2014-02-06       Impact factor: 91.245

2.  Improving management of dehydration in children younger than 5 years in low-and-middle-income countries.

Authors:  Shally Awasthi
Journal:  Lancet Glob Health       Date:  2016-08-23       Impact factor: 26.763

3.  Barriers to use of oral rehydration salts for child diarrhea in the private sector: evidence from India.

Authors:  Zachary Wagner; Manan Shah; Neeraj Sood
Journal:  J Trop Pediatr       Date:  2014-11-10       Impact factor: 1.165

Review 4.  Progress and barriers for the control of diarrhoeal disease.

Authors:  Mathuram Santosham; Aruna Chandran; Sean Fitzwater; Christa Fischer-Walker; Abdullah H Baqui; Robert Black
Journal:  Lancet       Date:  2010-07-03       Impact factor: 79.321

5.  Increasing coverage of pediatric diarrhea treatment in high-burden countries.

Authors:  Kate Schroder; Audrey Battu; Leslie Wentworth; Jason Houdek; Chizoba Fashanu; Owens Wiwa; Rosemary Kihoto; Gerald Macharia; Naresh Trikha; Parth Bahuguna; Harkesh Dabas; Damien Kirchoffer; Lorna Muhirwe; Patricia Mucheri; Andrew Musoke; Felix Lam
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

6.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

7.  Predictors of Oral Rehydration Therapy use among under-five children with diarrhea in Eastern Ethiopia: a community based case control study.

Authors:  Bezatu Mengistie; Yemane Berhane; Alemayehu Worku
Journal:  BMC Public Health       Date:  2012-11-24       Impact factor: 3.295

8.  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Infect Dis       Date:  2018-09-19       Impact factor: 25.071

9.  Progress in the use of ORS and zinc for the treatment of childhood diarrhea.

Authors:  Robert E Black
Journal:  J Glob Health       Date:  2019-06       Impact factor: 7.664

10.  Antenatal care use in Ethiopia: a spatial and multilevel analysis.

Authors:  Teketo Kassaw Tegegne; Catherine Chojenta; Theodros Getachew; Roger Smith; Deborah Loxton
Journal:  BMC Pregnancy Childbirth       Date:  2019-11-01       Impact factor: 3.007

View more
  1 in total

1.  Determinants of oral rehydration salt utilization among under-five children with diarrhea in Ethiopia: A multilevel mixed-effect analysis.

Authors:  Desalegn Girma; Zinie Abita; Alemnew Wale; Gossa Fetene
Journal:  SAGE Open Med       Date:  2022-01-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.